The hereditary angioedema (HAE) market continues to witness robust growth owing to increasing disease awareness and improved diagnostic capabilities. Recent innovations in therapeutic options coupled with supportive regulatory frameworks have significantly shaped the market dynamics. With rising incidence rates and an expanding patient pool, the market is positioned for sustained adva... https://www.coherentmarketinsights.com/market-insight/hereditary-angioedema-market-1292